184 related articles for article (PubMed ID: 35187488)
1. Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation.
de Andrade Costa A; Chatterjee J; Cobb O; Cordell E; Chao A; Schaeffer S; Goldstein A; Dahiya S; Gutmann DH
Neurooncol Adv; 2022; 4(1):vdab194. PubMed ID: 35187488
[TBL] [Abstract][Full Text] [Related]
2. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.
Guo X; Pan Y; Gutmann DH
Neuro Oncol; 2019 Oct; 21(10):1250-1262. PubMed ID: 31111915
[TBL] [Abstract][Full Text] [Related]
3. RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.
De Andrade Costa A; Chatterjee J; Cobb O; Sanapala S; Scheaffer S; Guo X; Dahiya S; Gutmann DH
Neuro Oncol; 2022 Jan; 24(1):14-26. PubMed ID: 34043012
[TBL] [Abstract][Full Text] [Related]
4. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.
Solga AC; Pong WW; Kim KY; Cimino PJ; Toonen JA; Walker J; Wylie T; Magrini V; Griffith M; Griffith OL; Ly A; Ellisman MH; Mardis ER; Gutmann DH
Neoplasia; 2015 Oct; 17(10):776-88. PubMed ID: 26585233
[TBL] [Abstract][Full Text] [Related]
5. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
Amato A; Imbimbo BP; Falsini B
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
[TBL] [Abstract][Full Text] [Related]
7. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
8. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.
Chatterjee J; Sanapala S; Cobb O; Bewley A; Goldstein AK; Cordell E; Ge X; Garbow JR; Holtzman MJ; Gutmann DH
Nat Commun; 2021 Dec; 12(1):7122. PubMed ID: 34880260
[TBL] [Abstract][Full Text] [Related]
9. NF1 mutation drives neuronal activity-dependent initiation of optic glioma.
Pan Y; Hysinger JD; Barron T; Schindler NF; Cobb O; Guo X; Yalçın B; Anastasaki C; Mulinyawe SB; Ponnuswami A; Scheaffer S; Ma Y; Chang KC; Xia X; Toonen JA; Lennon JJ; Gibson EM; Huguenard JR; Liau LM; Goldberg JL; Monje M; Gutmann DH
Nature; 2021 Jun; 594(7862):277-282. PubMed ID: 34040258
[TBL] [Abstract][Full Text] [Related]
10. Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of
Pan Y; Xiong M; Chen R; Ma Y; Corman C; Maricos M; Kindler U; Semtner M; Chen YH; Dahiya S; Gutmann DH
Genes Dev; 2018 Apr; 32(7-8):491-496. PubMed ID: 29632086
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects.
Tang Y; Gutmann DH
Cancer Manag Res; 2023; 15():667-681. PubMed ID: 37465080
[TBL] [Abstract][Full Text] [Related]
12. NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.
Anastasaki C; Chatterjee J; Koleske JP; Gao Y; Bozeman SL; Kernan CM; Marco Y Marquez LI; Chen JK; Kelly CE; Blair CJ; Dietzen DJ; Kesterson RA; Gutmann DH
Neuro Oncol; 2024 Apr; ():. PubMed ID: 38607967
[TBL] [Abstract][Full Text] [Related]
13. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Solga AC; Gianino SM; Gutmann DH
Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
[TBL] [Abstract][Full Text] [Related]
14. Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.
Toonen JA; Solga AC; Ma Y; Gutmann DH
J Exp Med; 2017 Jan; 214(1):17-25. PubMed ID: 27923908
[TBL] [Abstract][Full Text] [Related]
15. Brain injury drives optic glioma formation through neuron-glia signaling.
Chatterjee J; Koleske JP; Chao A; Sauerbeck AD; Chen JK; Qi X; Ouyang M; Boggs LG; Idate R; Marco Y Marquez LI; Kummer TT; Gutmann DH
Acta Neuropathol Commun; 2024 Feb; 12(1):21. PubMed ID: 38308315
[TBL] [Abstract][Full Text] [Related]
16. Midkine activation of CD8
Guo X; Pan Y; Xiong M; Sanapala S; Anastasaki C; Cobb O; Dahiya S; Gutmann DH
Nat Commun; 2020 May; 11(1):2177. PubMed ID: 32358581
[TBL] [Abstract][Full Text] [Related]
17. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.
Daginakatte GC; Gianino SM; Zhao NW; Parsadanian AS; Gutmann DH
Cancer Res; 2008 Dec; 68(24):10358-66. PubMed ID: 19074905
[TBL] [Abstract][Full Text] [Related]
18. Whole tumor RNA-sequencing and deconvolution reveal a clinically-prognostic PTEN/PI3K-regulated glioma transcriptional signature.
Pan Y; Bush EC; Toonen JA; Ma Y; Solga AC; Sims PA; Gutmann DH
Oncotarget; 2017 Aug; 8(32):52474-52487. PubMed ID: 28881745
[TBL] [Abstract][Full Text] [Related]
19. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
Freret ME; Gutmann DH
J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.
Simmons GW; Pong WW; Emnett RJ; White CR; Gianino SM; Rodriguez FJ; Gutmann DH
J Neuropathol Exp Neurol; 2011 Jan; 70(1):51-62. PubMed ID: 21157378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]